SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-182231
Filing Date
2024-07-22
Accepted
2024-07-22 16:19:58
Documents
2
Period of Report
2024-07-22
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d863184d8k.htm 8-K 18020
2 EX-3.1 d863184dex31.htm EX-3.1 28105
  Complete submission text file 0001193125-24-182231.txt   47320
Mailing Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121 (858) 267-4467
Artiva Biotherapeutics, Inc. (Filer) CIK: 0001817241 (see all company filings)

IRS No.: 863614316 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42179 | Film No.: 241131751
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)